Global Malignant Ascites Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Malignant Ascites Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
The most common malignancies associated with the development of ascites include cancers of the colon/rectum, ovary, breast, lung, pancreas, liver and lymphoma. Treatment strategies include paracentesis, diuretics and peritoneovenous shunts and so on.
Malignant Ascites Treatment report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Malignant Ascites Treatment market is projected to reach US$ 674.6 million in 2034, increasing from US$ 484 million in 2022, with the CAGR of 4.8% during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
Global Malignant Ascites Treatment key players include BD, B. Braun, Pfizer, Merit Medical Systems, Pfm Medical Ag, etc. Global top five manufacturers hold a share about 40%. North America is the largest market, with a share about 30%, followed by Europe and Middle East & Africa, both have a share about 60 percent. In terms of product, Paracentesis is the largest segment, with a share over 65%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Malignant Ascites Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
BD
Pfizer
B. Braun
Merit Medical Systems
Pfm Medical Ag
Medtronic
CMP Pharma
GI Supply (Laborie Medical Technologies)
The Surgical Company Group
Sequana Medical
PharmaCyte Biotech
BioVie
Clover Biopharmaceuticals
Segment by Type
Paracentesis
Chemotherapy
Surgical Treatment
Others
Hospitals
Clinics
Homecare
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Malignant Ascites Treatment market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Malignant Ascites Treatment introduction, etc. Malignant Ascites Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Malignant Ascites Treatment market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Malignant Ascites Treatment report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Malignant Ascites Treatment market is projected to reach US$ 674.6 million in 2034, increasing from US$ 484 million in 2022, with the CAGR of 4.8% during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
Global Malignant Ascites Treatment key players include BD, B. Braun, Pfizer, Merit Medical Systems, Pfm Medical Ag, etc. Global top five manufacturers hold a share about 40%. North America is the largest market, with a share about 30%, followed by Europe and Middle East & Africa, both have a share about 60 percent. In terms of product, Paracentesis is the largest segment, with a share over 65%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Malignant Ascites Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
BD
Pfizer
B. Braun
Merit Medical Systems
Pfm Medical Ag
Medtronic
CMP Pharma
GI Supply (Laborie Medical Technologies)
The Surgical Company Group
Sequana Medical
PharmaCyte Biotech
BioVie
Clover Biopharmaceuticals
Segment by Type
Paracentesis
Chemotherapy
Surgical Treatment
Others
Segment by Application
Hospitals
Clinics
Homecare
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Malignant Ascites Treatment market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Malignant Ascites Treatment introduction, etc. Malignant Ascites Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Malignant Ascites Treatment market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices